2022
DOI: 10.1111/apt.17194
|View full text |Cite
|
Sign up to set email alerts
|

Letter: efficacy of peppermint oil in irritable bowel syndrome

Abstract: LINKED CONTENTThis article is linked to Ingrosso et al papers. To view these articles, visit https://doi.org/10.1111/apt.17179 and https://doi.org/10.1111/apt.17197

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 6 publications
0
2
0
Order By: Relevance
“…Xu and Giang for their letter. 1 We performed a metaanalysis of randomised controlled trials (RCTs) of peppermint oil in irritable bowel syndrome (IBS) 2 ; hence, all eligible studies were RCTs.The risk of bias in studies was assessed according to the Cochrane risk of bias tool, 3 as recommended, and as we have used in multiple other meta-analyses in IBS. [4][5][6][7][8] We agree that there were high levels of heterogeneity in two of our analyses, a fact that we had acknowledged.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Xu and Giang for their letter. 1 We performed a metaanalysis of randomised controlled trials (RCTs) of peppermint oil in irritable bowel syndrome (IBS) 2 ; hence, all eligible studies were RCTs.The risk of bias in studies was assessed according to the Cochrane risk of bias tool, 3 as recommended, and as we have used in multiple other meta-analyses in IBS. [4][5][6][7][8] We agree that there were high levels of heterogeneity in two of our analyses, a fact that we had acknowledged.…”
mentioning
confidence: 99%
“…Xu and Giang for their letter. 1 We performed a metaanalysis of randomised controlled trials (RCTs) of peppermint oil in irritable bowel syndrome (IBS) 2 ; hence, all eligible studies were RCTs.…”
mentioning
confidence: 99%